Macrophages (grey) attacking tumor cells (green)
Macrophages (grey) attacking tumor cells ( green ) © Manfred Ogris, Magdalena Billerhart, University of Vienna - A team at the Department for Pharmaceutical Sciences developed a therapy concept that could stop tumor growth. The immune system protects the body from cancer. To protect healthy body cells from its own immune system, they have developed a protective shield: the protein CD47 is a so called "don't eat me" signal, which tells the immune cells to stand back. Tumor cells exploit this CD47-based protection strategy for evading the immune system, by increasing presentation of CD47 on their cell surface. At the Department for Pharmaceutical Sciences, a team led by Manfred Ogris developed a therapy concept for programming the tumor cells to produce on their own a CD47-blocking and immune-activation fusion protein. This therapy approach could stop tumor growth. On phagocytic cells, also called macrophages, and other immune cells the ligand for CD47, namely SIRPa, can be found.
TO READ THIS ARTICLE, CREATE YOUR ACCOUNT
And extend your reading, free of charge and with no commitment.
Your Benefits
- Access to all content
- Receive newsmails for news and jobs
- Post ads